BSE Live
Feb 20, 16:01Prev. Close
510.55
Open Price
542.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Feb 20, 15:59Prev. Close
511.30
Open Price
511.30
Bid Price (Qty.)
510.20 (2)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Rossari Biotech (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 4.70 | 4.19 | 5.75 | 6.15 | 5.75 | |
| Net CashFlow From Operating Activities | 0.01 | 6.24 | 2.28 | 1.94 | 2.28 | |
| Net Cash Used In Investing Activities | -2.13 | 3.53 | 6.17 | 5.24 | -6.17 | |
| Net Cash Used From Financing Activities | 2.75 | 2.89 | -3.89 | -3.18 | -3.89 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 0.62 | 12.66 | 4.56 | 4.00 | -7.77 | |
| Cash And Cash Equivalents Begin of Year | 0.33 | 0.51 | 0.35 | 0.00 | 0.00 | |
| Cash And Cash Equivalents End Of Year | 0.95 | 13.17 | 4.91 | 0.00 | 0.00 |
20.01.2026
Rossari Consolidated December 2025 Net Sales at Rs 581.68 crore, up 13.45% Y-o-Y
19.01.2026
Rossari Standalone December 2025 Net Sales at Rs 450.66 crore, up 22.37% Y-o-Y
16.10.2025
Rossari Consolidated September 2025 Net Sales at Rs 586.11 crore, up 17.61% Y-o-Y
16.10.2025
Rossari Standalone September 2025 Net Sales at Rs 419.51 crore, up 24.86% Y-o-Y